{
    "clinical_study": {
        "@rank": "146254", 
        "arm_group": [
            {
                "arm_group_label": "Clonidine+ Saline", 
                "arm_group_type": "Active Comparator", 
                "description": "Clonidine 0.15 mg and saline 0.15 mg/kg"
            }, 
            {
                "arm_group_label": "Clonidine + Naloxone", 
                "arm_group_type": "Active Comparator", 
                "description": "Clonidine 0.15 mg and Naloxone 0.15 mg/kg"
            }, 
            {
                "arm_group_label": "Placebo +Naloxone", 
                "arm_group_type": "Active Comparator", 
                "description": "Placebo 0.15 mg+ naloxone 0.15 mg/kg"
            }, 
            {
                "arm_group_label": "Placebo +saline", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo 0.15 mg+ saline 0.15 mg/kg"
            }
        ], 
        "brief_summary": {
            "textblock": "The role of alpha2 receptor agonist on pain perception and modulation will be examined. In\n      addition whether this is mediated through the opioid system will be examined. Pain\n      perception and modulation will be examined before and after administration of Clonidine or\n      placebo together with Naloxone or saline."
        }, 
        "brief_title": "The Relationships Between the Noradrenergic, Opioid and Pain System", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Experimental Pain Perception", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy volunteers\n\n          -  Age 18-40\n\n          -  No chronic disease\n\n        Exclusion Criteria:\n\n          -  Subjects who suffer from chronic pain / pain syndrome\n\n          -  use of anti-depressant or anti-psychotic drugs\n\n          -  suffering from cardiovascular disease\n\n          -  breast feeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01851486", 
            "org_study_id": "0393-12-RMB.CTIL"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Clonidine+ Saline", 
                    "Clonidine + Naloxone"
                ], 
                "description": "Clonidine 0.15 mg", 
                "intervention_name": "Clonidine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Clonidine + Naloxone", 
                    "Placebo +Naloxone"
                ], 
                "description": "naloxone 0.15 mg/kg", 
                "intervention_name": "Naloxone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Placebo +Naloxone", 
                    "Placebo +saline"
                ], 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Clonidine+ Saline", 
                    "Placebo +saline"
                ], 
                "intervention_name": "saline", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Clonidine", 
                "Naloxone"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 9, 2013", 
        "location": {
            "contact": {
                "email": "d_yarnitsky@rambam.health.gov.il", 
                "last_name": "David Yarnitsky"
            }, 
            "facility": {
                "address": {
                    "city": "Haifa", 
                    "country": "Israel"
                }, 
                "name": "Rambam Health Care Campus"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "4", 
        "overall_contact": {
            "email": "d_yarnitsky@rambam.health.gov.il", 
            "last_name": "David Yarnitsky, Prof."
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The change in pain perception (pain thresholds and pain ratings of suprathresholds stimuli) and in the excitatory and inhibitory pain modulation responses (assessed by the temporal summation and conditioned pain modulation paradigms) will be examined before and after administration of alpha 2 agonist with  and without mu receptor antagonist", 
            "measure": "The changes in pain responses after administration of alpha 2 agonist and mu receptor antagonist", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01851486"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rambam Health Care Campus", 
            "investigator_full_name": "d_yarnitsky", 
            "investigator_title": "Professor, Head on Neurology Department", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Rambam Health Care Campus", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rambam Health Care Campus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}